KEYWORDS: Transformers, Heart, Education and training, Computed tomography, Atherosclerosis, Angiography, Network architectures, Deep learning, Medicine, Medical research
Background: compare the performance of 2 novel deep learning networks—convolutional long short-term memory and transformer network—for artificial intelligence-based quantification of plaque volume and stenosis severity from CCTA. Methods: This was an international multicenter study of patients undergoing CCTA at 11 sites. The deep learning (DL) convolutional neural networks were trained to segment coronary plaque in 921 patients (5,045 lesions). The training dataset was further split temporally into training (80%) and internal validation (20%) datasets. The primary DL architecture was a hierarchical convolutional long short- term memory (ConvLSTM) network. This was compared against a TransUNet network, which combines the abilities of Vision Transformer with U-Net, enabling the capture of in-depth localization information while modeling long-range dependencies. Following training and internal validation, the both DL networks were applied to an external validation cohort of 162 patients (1,468 lesions) from the SCOT-HEART trial. Results: In the external validation cohort, agreement between DL and expert reader measurements was stronger when using the ConvLSTM network than with TransUNet, for both per-lesion total plaque volume (ICC 0·953 vs 0.830) and percent diameter stenosis (ICC 0·882 vs 0.735; both p<0.001). The ConvLSTM network showed higher per-cross-section overlap with expert reader segmentations (as measured by the Dice coefficient) compared to TransUnet, for vessel wall (0.947 vs 0.946), lumen (0.93 vs 0.92), and calcified plaque (0.87 vs 0.86; p<0.0001 for all), with similar execution times. Conclusions: In a direct comparison with external validation, the ConvLSTM network yielded higher agreement with expert readers for quantification of total plaque volume and stenosis severity compared to TransUnet, with faster execution times.
Preclinical studies and clinical diagnostics increasingly rely on optical techniques to visualize internal organs. Miniaturised catheters or endoscopes are necessary for imaging small and/or delicate arteries. However, current lens fabrication methods limit the performance of these ultrathin devices, resulting in a poor combination of resolution, depth of focus and multimodal imaging capability. This talk will introduce our latest research to address these combined challenges. In particular, we have utilized 3D micro-printing technology to fabricate freeform optics directly onto an optical fiber to achieve freeform designs for aberration-corrected optical coherence tomography (OCT) and to enable highly-sensitive multimodal fluorescence+OCT imaging in vivo.
3D micro-printing enables the formation of complex shapes at a print resolution of tens of nanometers using two-photon lithography. Our team have explored the use of 3D micro-printing to fabricate complex optical geometries directly on the end of a fiber. In this work, we have developed a lens-in-lens design that enables in-vivo high-sensitivity fluorescence and OCT imaging through a single-fiber-based probe, with a diameter <550 microns including a protective catheter sheath. In a parallel work, we have also fabricated a side-facing OCT fiber probe (<300 microns diameter) creating an elongated Bessel beam and simultaneously correct for aberrations.
Background: Coronary computed tomography angiography (CCTA) allows non-invasive assessment of luminal stenosis and coronary atherosclerotic plaque. We aimed to develop and externally validate an artificial intelligence-based deep learning (DL) network for CCTA-based measures of plaque volume and stenosis severity. Methods: This was an international multicenter study of 1,183 patients undergoing CCTA at 11 sites. A novel DL convolutional neural network was trained to segment coronary plaque in 921 patients (5,045 lesions). The DL architecture consisted of a novel hierarchical convolutional long short-term memory (ConvLSTM) Network. The training set was further split temporally into training (80%) and internal validation (20%) datasets. Each coronary lesion was assessed in a 3D slab about the vessel centrelines. Following training and internal validation, the model was applied to an independent test set of 262 patients (1,469 lesions), which included an external validation cohort of 162 patients Results: In the test set, there was excellent agreement between DL and clinician expert reader measurements of total plaque volume (intraclass correlation coefficient [ICC] 0.964) and percent diameter stenosis (ICC 0.879; both p<0.001, see tables and figure). The average per-patient DL plaque analysis time was 5.7 seconds versus 25-30 minutes taken by experts. There was significantly higher overlap measured by the Dice coefficient (DC) for ConvLSTM compared to UNet (DC for vessel 0.94 vs 0.83, p<0.0001; DC for lumen and plaque 0.90 vs 0.83, p<0.0001) or DeepLabv3 (DC for vessel both 0.94; DC for lumen and plaque 0.89 vs 0.84, p<0.0001). Conclusions: A novel externally validated artificial intelligence-based network provides rapid measurements of plaque volume and stenosis severity from CCTA which agree closely with clinician expert readers.
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.